SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001062993-23-023078
Filing Date
2023-12-22
Accepted
2023-12-22 16:07:17
Documents
1
Period of Report
2023-12-20

Document Format Files

Seq Description Document Type Size
1 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES form3.html 3  
1 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES form3.xml 3 2068
  Complete submission text file 0001062993-23-023078.txt   3931
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES, INC. (Reporting) CIK: 0000882095 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38869 | Film No.: 231509840
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 430 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016
Business Address 430 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016 0114318906360
HOOKIPA Pharma Inc. (Issuer) CIK: 0001760542 (see all company filings)

IRS No.: 815395687 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)